These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane. Nap AW; Dunselman GA; Griffioen AW; Mayo KH; Evers JL; Groothuis PG Fertil Steril; 2005 Mar; 83(3):793-5. PubMed ID: 15749522 [TBL] [Abstract][Full Text] [Related]
3. Effect of recombinant human endostatin on endometriosis in mice. Jiang HQ; Li YL; Zou J Chin Med J (Engl); 2007 Jul; 120(14):1241-6. PubMed ID: 17697575 [TBL] [Abstract][Full Text] [Related]
4. [Human endostatin antiangiogenic gene therapy mediated by recombinant adeno-associated virus vector in nude mouse with endometriosis]. Sun JJ; Yin LR; Mi RR; Ma HD; Guo SJ; Shi Y; Gu YJ Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):45-50. PubMed ID: 20367926 [TBL] [Abstract][Full Text] [Related]
5. ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model. Wang Y; Lin M; Weng H; Wang X; Yang L; Liu F Am J Obstet Gynecol; 2014 Jun; 210(6):531.e1-8. PubMed ID: 24495669 [TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors. Dirkx AE; oude Egbrink MG; Castermans K; van der Schaft DW; Thijssen VL; Dings RP; Kwee L; Mayo KH; Wagstaff J; Bouma-ter Steege JC; Griffioen AW FASEB J; 2006 Apr; 20(6):621-30. PubMed ID: 16581970 [TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic agents are effective inhibitors of endometriosis. Hull ML; Charnock-Jones DS; Chan CL; Bruner-Tran KL; Osteen KG; Tom BD; Fan TP; Smith SK J Clin Endocrinol Metab; 2003 Jun; 88(6):2889-99. PubMed ID: 12788903 [TBL] [Abstract][Full Text] [Related]
8. Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. van der Schaft DW; Seftor RE; Seftor EA; Hess AR; Gruman LM; Kirschmann DA; Yokoyama Y; Griffioen AW; Hendrix MJ J Natl Cancer Inst; 2004 Oct; 96(19):1473-7. PubMed ID: 15467037 [TBL] [Abstract][Full Text] [Related]
9. Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis. Beecken WD; Engl T; Blaheta R; Bentas W; Achilles EG; Jonas D; Shing Y; Camphausen K Angiogenesis; 2004; 7(1):69-73. PubMed ID: 15302998 [TBL] [Abstract][Full Text] [Related]
10. Natural therapies assessment for the treatment of endometriosis. Ricci AG; Olivares CN; Bilotas MA; Bastón JI; Singla JJ; Meresman GF; Barañao RI Hum Reprod; 2013 Jan; 28(1):178-88. PubMed ID: 23081870 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenesis therapy of endometriosis using PAMAM as a gene vector in a noninvasive animal model. Wang N; Liu B; Liang L; Wu Y; Xie H; Huang J; Guo X; Tan J; Zhan X; Liu Y; Wang L; Ke P Biomed Res Int; 2014; 2014():546479. PubMed ID: 25050361 [TBL] [Abstract][Full Text] [Related]
12. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799 [TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis. Song WW; Lu H; Hou WJ; Xu GX; Zhang JH; Sheng YH; Cheng MJ; Zhang R Int J Clin Exp Pathol; 2014; 7(11):7752-9. PubMed ID: 25550812 [TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Van Langendonckt A; Donnez J; Defrère S; Dunselman GA; Groothuis PG Mol Hum Reprod; 2008 May; 14(5):259-68. PubMed ID: 18430758 [TBL] [Abstract][Full Text] [Related]
15. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Bourlev V; Volkov N; Pavlovitch S; Lets N; Larsson A; Olovsson M Reproduction; 2006 Sep; 132(3):501-9. PubMed ID: 16940291 [TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Laschke MW; Elitzsch A; Vollmar B; Vajkoczy P; Menger MD Hum Reprod; 2006 Jan; 21(1):262-8. PubMed ID: 16172144 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis. Cohen J; Naoura I; Castela M; Von N'Guyen T; Oster M; Fontaine R; Chabbert-Buffet N; Darai E; Aractingi S Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():70-7. PubMed ID: 25461356 [TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model. Xu H; Lui WT; Chu CY; Ng PS; Wang CC; Rogers MS Hum Reprod; 2009 Mar; 24(3):608-18. PubMed ID: 19088106 [TBL] [Abstract][Full Text] [Related]
19. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis. Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695 [TBL] [Abstract][Full Text] [Related]